3650 results for «318»

Filter By

3650 results

Transcatheter mitral valve implantation

22 Nov 2021 – From PCR London Valves 2021

Shot in the simulation lab at the PCR London Valves 2021 Congress, this session enables you to see some of the anatomical specimens and devices currently used for transcatheter mitral valve replacement and witness a Tendyne implantation from start to finish using a simulated heart.

Transcatheter mitral valve implantation

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session presents different kinds of complications in mitral procedures based on clinical cases: discuss the case of an 82-year-old male patient with symptomatic severe ischemic secondary mitral regurgitation, coronary artery disease, diabetes, and chronic kidney disease, among others!

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

Transcatheter tricuspid valve interventions: the future

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...

Transcatheter tricuspid valve interventions: the future

Coronary access following TAVI

23 Nov 2021 – From PCR London Valves 2021

Using the anatomy and imaging section and simulators, our experts dissect the case of a typical TAVI patient, an 81-year-old male, former smoker, with hypertension, dyslipidemia, and gastric ulcer, symptomatic of effort dyspnea, with marked left ventricular hypertrophy and all the parameters of severe aortic stenosis,...

Coronary access following TAVI

Tricuspid valve disease: guidelines and beyond

23 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...

Tricuspid valve disease: guidelines and beyond

Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.

Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement

Commissural alignment for TAVI

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session shot in the simulation lab, learn tips and tricks for achieving commissural alignment, review the strategy for improving TAVR outcomes, and discuss how to get the right imaging, the right tools, and the right patients. 

Commissural alignment for TAVI

Closing Ceremony

23 Nov 2021 – From PCR London Valves 2021

Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...

Closing Ceremony

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation
Didn’t find what you were looking for?